Treatment Trials

3 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria
      Description

      This study will evaluate the clinical efficacy and safety of a combination of leflunomide and orotic acid in kidney transplant patients with high levels of Polyoma BK viruria for the purpose of preventing Polyoma BK viremia and Nephropathy that could lead to kidney transplant loss from viral damage, acute rejection or both.

      Conditions
      ViruriaViremia
      Talk to us
      COMPLETED
      CMX001 in Post-transplant Patients With BK Virus Viruria
      Description

      This was a randomized, double-blind, multiple-dose placebo-controlled study of oral brincidofovir (BCV) in hematopoietic stem cell transplant and renal transplant recipients with BK virus viruria.

      Conditions
      Viruria
      Talk to us
      COMPLETED
      A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
      Description

      To determine the safety, tolerance, and potential in vivo antiviral effects of five dosage levels and a dose to be determined of human anti-cytomegalovirus (CMV) monoclonal antibody (SDZ MSL-109; formerly SDZ 89-109) when administered once every 2 weeks for a total of 12 doses to patients with either AIDS or eligible AIDS-related complex (ARC) and with culture proven evidence of CMV viremia and/or viruria. Sandoglobulin will be employed as a comparative control.

      Conditions
      Cytomegalovirus InfectionsHIV Infections
      Talk to us